Why is cinacalcet used in secondary hyperparathyroidism?
Cinacalcet effectively reduced parathyroid hormone levels independently of disease severity or changes in vitamin D sterol dose. Conclusions: Cinacalcet lowers parathyroid hormone levels and improves calcium-phosphorus homeostasis in patients receiving hemodialysis who have uncontrolled secondary hyperparathyroidism.
Can sensipar be used for primary hyperparathyroidism?
Sensipar should not be used for primary hyperparathyroidism with high blood calcium. Sensipar (Cinacalcet) can be used for secondary (renal failure) hyperparathyroidism. If you are not getting kidney dialysis, then you probably should not take Sensipar.
What is cinacalcet 90 mg used for?
Cinacalcet is used alone or with other medications to treat secondary hyperparathyroidism (a condition in which the body produces too much parathyroid hormone [a natural substance needed to control the amount of calcium in the blood] which can cause serious problems with the bones, heart, blood vessels, and lungs) in …
What is cinacalcet HCL used for?
Cinacalcet is used to treat hyperparathyroidism in patients with chronic kidney disease who are on dialysis. Hyperparathyroidism is a condition that is caused when the parathyroid glands located in the neck make too much parathyroid hormone (PTH).
Why is serum phosphate low in primary hyperparathyroidism?
In primary hyperparathyroidism, serum phosphate levels are often low because of the phosphaturic effects of parathyroid hormone. Serum phosphate levels may also be low in the presence of a malignant growth that secretes ectopic parathyroid hormone or parathyroid-related peptide.
How effective is cinacalcet for primary hyperparathyroidism?
Cinacalcet, a calcimimetic agent, lowers calcium and (modestly) plasma PTH concentrations, but does not improve BMD or reduce hypercalciuria. Contemporary medical management of primary hyperparathyroidism: a systematic review.
What are the treatment options for primary hyperparathyroidism?
Although parathyroidectomy remains the only curative approach to most primary hyperparathyroidism cases, medical treatment with cinacalcet HCl has been proven to be a reasonable alternative for several patient subgroups. Cinacalcet almost always controls hypercalcemia and hypophosphatemia sufficiently.
Does cinacalcet increase the risk of nephrolithiasis in primary HPT?
Nephrolithiasis was not found to occur more frequently in cinacalcet trial groups, but urine calcium excretion as one major risk factor of this complication of primary HPT may increase on cinacalcet.
Does cinacalcet affect calcium phosphate levels?
The serum calcium–phosphorus product declined by 15 percent in the cinacalcet group and remained unchanged in the placebo group (P<0.001). Cinacalcet effectively reduced parathyroid hormone levels independently of disease severity or changes in vitamin D sterol dose.
